Patients’ knowledge and perspectives on wet age-related macular degeneration and its treatment
Sushma Kandula1, Jeffrey C Lamkin1, Teresa Albanese2, Deepak P Edward11Department of Ophthalmology, 2Health Service Research and Education Institute, SUMMA Health System, Akron OH, USASummary: There have been no studies examining the level of understanding age-related macular degeneration (ARMD) pat...
Guardado en:
Autores principales: | Sushma Kandula, Jeffrey C Lamkin, Teresa Albanese, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d1591327bb04dd7864d2dba72fc85c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
por: Neffendorf JE, et al.
Publicado: (2015) -
Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
por: Keles S, et al.
Publicado: (2014) -
Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
por: Dervenis N, et al.
Publicado: (2016) -
Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
por: Stewart MW
Publicado: (2012) -
Spectral domain OCT versus time domain OCT in the evaluation of macular features related to wet age-related macular degeneration
por: Isola V, et al.
Publicado: (2012)